Rapport Therapeutics, Inc. Common Stock Financial Flexibility Index
Rapport Therapeutics, Inc. Common Stock financial flexibility index. Rapport Therapeutics, Inc. Common Stock (RAPP) has a Financial Flexibility Index of -1.51x as of June 2026. Free cash flow of $-54.35 Million (operating CF $-54.52 Million minus capex $164.00K) represents -2% of total liabilities ($36.06 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Rapport Therapeutics, Inc. Common Stock (2022–2025)
Financial flexibility index of Rapport Therapeutics, Inc. Common Stock from 2022 to 2025. Historical Financial Flexibility Index trend for Rapport Therapeutics, Inc. Common Stock across 4 annual periods. Explore RAPP operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Rapport Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2022–2025)
Rapport Therapeutics, Inc. Common Stock financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Rapport Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see RAPP cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.13x | $-86.86 Million | $-87.47 Million | $27.78 Million | ▲ +52.4% |
| 2024 | -6.57x | $-62.42 Million | $-64.83 Million | $9.51 Million | ▼ -4554.3% |
| 2023 | -0.14x | $-25.55 Million | $-27.18 Million | $181.06 Million | ▲ +42.3% |
| 2022 | -0.24x | $-2.96 Million | $-3.24 Million | $12.10 Million | — |